MSFT 410.37 -0.8486% AAPL 222.91 0.4144% NVDA 135.3699 0.0% GOOGL 171.29 -0.0233% GOOG 172.65 -0.3003% AMZN 197.93 -0.6119% META 567.16 -0.5297% AVGO 168.92 -0.9732% TSLA 248.98 -0.4319% TSM 192.98 -1.9261% LLY 818.79 -0.5333% V 290.73 -0.4588% JPM 222.93 -0.8539% UNH 567.53 -0.0308% NVO 111.97 -0.1684% WMT 82.19 0.4768% LVMUY 131.75 -0.6335% XOM 114.95 -1.6849% LVMHF 660.0 -0.6323% MA 508.28 -0.2316%
Last update at 2024-11-01T20:00:00Z
BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division
Thu 17 Oct 24, 02:58 PMIs Bruker Corporation (BRKR) the Most Profitable Mid-Cap Stock to Invest In Now?
Thu 17 Oct 24, 04:08 AMUS Growth Stocks With High Insider Ownership In October 2024
Wed 09 Oct 24, 07:31 PMBRKR Stock Might Gain From the Newly Launched OptoVolt Module
Wed 09 Oct 24, 12:44 PMBruker Corporation (NASDAQ:BRKR) Delivered A Better ROE Than Its Industry
Tue 08 Oct 24, 12:25 PMBruker Stock Gains From Its Latest Acquisition of Dynamic Biosensors
Mon 07 Oct 24, 06:06 PMHere's Why You Should Retain BRKR Stock in Your Portfolio Now
Thu 03 Oct 24, 12:20 PMAccelerate Diagnostics Stock Down Despite FDA Clearance for Arc System
Tue 01 Oct 24, 04:12 PMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 413.90M | 393.60M | 225.80M | 280.40M | 244.70M |
Minority interest | -1.90000M | -3.50000M | 7.60M | 0.80M | 1.30M |
Net income | 296.60M | 277.10M | 157.80M | 197.20M | 179.70M |
Selling general administrative | 610.80M | 564.50M | 477.80M | 500.20M | 444.70M |
Selling and marketing expenses | -3.40000M | -3.30000M | -9.20000M | - | - |
Gross profit | 1305.70M | 1209.60M | 939.80M | 995.30M | 900.00M |
Reconciled depreciation | 88.00M | 89.10M | 80.40M | 75.60M | 64.90M |
Ebit | 432.70M | 413.30M | 248.30M | 300.90M | 281.90M |
Ebitda | 550.40M | 516.70M | 353.60M | 383.00M | 346.80M |
Depreciation and amortization | 117.70M | 103.40M | 105.30M | 82.10M | 64.90M |
Non operating income net other | -18.80000M | -19.70000M | -22.50000M | -20.50000M | -17.70000M |
Operating income | 432.70M | 413.30M | 248.30M | 300.90M | 262.40M |
Other operating expenses | 2068.30M | 1990.30M | 1714.30M | 1765.20M | 1613.70M |
Interest expense | 16.10M | 14.30M | 14.40M | 16.00M | 12.60M |
Tax provision | 116.40M | 113.00M | 64.40M | 82.40M | 63.70M |
Interest income | 4.10M | 0.90M | 3.20M | 1.30M | 1.20M |
Net interest income | -18.80000M | -19.70000M | -22.50000M | -14.70000M | -11.40000M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 116.40M | 113.00M | 64.40M | 82.40M | 63.70M |
Total revenue | 2530.70M | 2417.90M | 1987.50M | 2072.60M | 1895.60M |
Total operating expenses | 843.30M | 782.00M | 666.60M | 687.90M | 618.10M |
Cost of revenue | 1225.00M | 1208.30M | 1047.70M | 1077.30M | 995.60M |
Total other income expense net | -18.80000M | -19.70000M | -22.50000M | -20.50000M | -19.50000M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 298.50M | 280.60M | 168.90M | 198.00M | 181.00M |
Net income applicable to common shares | 296.60M | 277.10M | 157.80M | 197.20M | 179.70M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 4249.90M | 3618.50M | 3650.00M | 3047.90M | 2771.50M |
Intangible assets | 330.50M | 270.90M | 211.80M | 229.10M | 603.50M |
Earning assets | - | - | - | - | - |
Other current assets | 85.80M | 202.60M | 176.60M | 165.50M | 172.00M |
Total liab | 2836.60M | 2486.70M | 2565.20M | 2072.30M | 1854.40M |
Total stockholder equity | 1377.20M | 1125.70M | 1084.60M | 975.60M | 917.10M |